On the Therapeutic Scope of Low-Dose IL-2. Response To: ‘Circulating Regulatory T Cells Were Absolutelydecreased in Dermatomyositis/Polymyositispatients and Restored by Low-Dose IL-2’ by Zhang Et Al

Annals of the Rheumatic Diseases - United Kingdom
doi 10.1136/annrheumdis-2019-216267
Full Text
Abstract

Available in full text

Date
Authors
Publisher

BMJ

Related search

Circulating Regulatory T Cells Were Absolutely Decreased in Dermatomyositis/Polymyositis Patients and Restored by Low-Dose IL-2

Annals of the Rheumatic Diseases
ImmunologyMolecular BiologyBiochemistryRheumatologyAllergyGenetics
2019English

Therapeutic Potential of Low-Dose IL-2 in Immune Thrombocytopenia: An Analysis of 3 Cases

Cytometry Part B - Clinical Cytometry
Forensic MedicinePathologyHistologyCell Biology
2018English

Negative Modulation of Suppressive HIV-specific Regulatory T Cells by IL-2 Adjuvanted Therapeutic Vaccine

PLoS Pathogens
ImmunologyMolecular BiologyVirologyMicrobiologyParasitologyGenetics
2017English

P134/O32 Selective Expansion of a Thymic-Derived and Functionally Competent Regulatory T Cell Population by Low-Dose IL-2 Therapy in Patients With Refractory SLE

2019English

Correction for Krieg Et Al., Improved IL-2 Immunotherapy by Selective Stimulation of IL-2 Receptors on Lymphocytes and Endothelial Cells

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2011English

THU0412 Absolute Reduction of Peripheral Cd4 + Regulatory T Cell Subset of Patients With Systemic Sclerosis and Its Restoration by Short-Term and Low Dose Il-2 Treatment

2018English

IL-2/CD25: A Long-Acting Fusion Protein That Promotes Immune Tolerance by Selectively Targeting the IL-2 Receptor on Regulatory T Cells

Journal of Immunology
AllergyImmunology
2018English

The Production of IL-10 by Human Regulatory T Cells Is Enhanced by IL-2 Through a STAT5-Responsive Intronic Enhancer in the IL-10 Locus

Journal of Immunology
AllergyImmunology
2008English

Construction of Self-Recognizing Regulatory T Cells From Conventional T Cells by Controlling CTLA-4 and IL-2 Expression

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy